Upregulation of persistent sodium conductances in familial ALS

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 2, 2010, Pages 222-227

  Vucic, Steve ^a   Kiernan, Matthew C ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SODIUM;

ADULT; AGED; AMPLITUDE MODULATION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FASCICULATION; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE CRAMP; NERVE CELL EXCITABILITY; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SODIUM CONDUCTANCE; STATISTICAL SIGNIFICANCE; UPREGULATION;

EID: 76549107634     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.183079     Document Type: Article

References (43)

1. Desai J, Swash M. Essentials of diagnosis. In: WR K, ed. Motor neuron disease. London: WB Saunders, 2002: 1-21.
2. Andersen P. Amyotrophic lateral sclerosis genetics with Mendelian inheritance. In: Brown R Jr, Swash M, Pasinelli P, eds. Amyotrophic lateral sclerosis, 2nd edn. London: Informa Healthcare, 2006: 187-207.
3. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
4. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve 2005;32:431-42.
5. Layzer RB. The origin of muscle fasciculations and cramps. Muscle Nerve 1994;17:1243-9.
6. Roth G. The origin of fasciculations. Ann Neurol 1982;12:542-7.
7. Roth G. Fasciculations and their F-response. Localisation of their axonal origin. J Neurol Sci 1984;63:299-306.
8. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1458-66.
9. Kanai K, Kuwabara S, Misawa S, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006;129:953-62.
10. Nakata M, Kuwabara S, Kanai K, et al. Distal excitability changes in motor axons in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1444-8.
11. Tamura N, Kuwabara S, Misawa S, et al. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol 2006;117:2451-8.
12. Mogyoros I, Kiernan MC, Burke D. Strengtheduration properties of human peripheral nerve. Brain 1996;119:439-47.
13. Kiernan M, Burke D. Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis. In: Eisen A, ed. Clinical neurophysiology of motor neuron diseases. Amsterdam: Elsevier, 2004:359-66.
14. Kanai K, Kuwabara S, Arai K, et al. Muscle cramp in MachadoeJoseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003;126:965-73.
15. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006;129:2436-46.
16. Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve 1992;15:219-24.
17. Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008;131:1540-50.
18. Bostock H. The strengtheduration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol 1983;341:59-74.
19. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997;498:277-94.
20. Kiernan MC, Burke D, Andersen KV, et al. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409.
21. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
22. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
23. Medical Research Council. Aid to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office, 1976.
24. Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605-11.
25. de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000;23:344-52.
26. Weiss G. Sur la possibilité de rendre comparables entre eux les appareils servant l'excitation électrique. Arch Ital Biol 1901;35:413-46.
27. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-58.
28. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001;112:1575-85.
29. Vucic S, Howells J, Trevillion L, et al. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006;33:477-86.
30. Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain 2001;124:816- 25.
31. Bostock H, Sharief MK, Reid G, et al. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995;118:217- 25.
32. Baker MD, Bostock H. Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. J Neurophysiol 1997;77:1503-13.
33. Kiernan MC, Mogyoros I, Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 1996;119:1099-105.
34. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982;323:117-44.
35. Mogyoros I, Kiernan M, Burke D, et al. Strengtheduration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998;121:851-9.
36. Kuo JJ, Siddique T, Fu R, et al. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 2005;563:843-54.
37. Pieri M, Carunchio I, Curcio L, et al. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 2009;215:368-79.
38. Amendola J, Gueritaud JP, d'Incamps BL, et al. Postnatal electrical and morphological abnormalities in lumbar motoneurons from transgenic mouse models of amyotrophic lateral sclerosis. Arch Ital Biol 2007;145:311-23.
39. Kiernan MC. Hyperexcitability, persistent Na+ conductances and neurodegeneration in amyotrophic lateral sclerosis. Exp Neurol 2009;218:1-4.
40. + channels. J Neurophysiol 1994;72:349-59.
41. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000;123:2542-51.
42. Brismar T. Electrical properties of isolated demyelinated rat nerve fibres. Acta Physiol Scand 1981;113:161-6.
43. Urbani A, Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 2000;12:3567-74.